Bisphosphonate related osteonecrosis of the jaw: A minipig large animal model

Bone

Volumn 51, Issue 3, 2012, Pages 592-599

  Pautke, Christoph ^a   Kreutzer, Kilian ^b   Weitz, Jochen ^b   Knödler, Martina ^b   Münzel, Daniela ^b   Wexel, Gabriele ^b   Otto, Sven ^a   Hapfelmeier, Alexander ^c   Stürzenbaum, Stephen ^d   Tischer, Thomas ^e  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Animal model; Bisphosphonate; Bisphosphonate related osteonecrosis of the jaw; Minipig; Ostoenecrosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE MODEL; HISTOPATHOLOGY; JAW OSTEONECROSIS; JAW RADIOGRAPHY; MINIPIG; NONHUMAN; TOOTH EXTRACTION; WOUND HEALING IMPAIRMENT;

ANIMALS; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; DISEASE MODELS, ANIMAL; MICROSCOPY, FLUORESCENCE; PARAFFIN EMBEDDING; SWINE; SWINE, MINIATURE; TOMOGRAPHY, X-RAY COMPUTED; TOOTH EXTRACTION;

EID: 84864763447     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.04.020     Document Type: Article

References (46)

1. Sambrook P., Cooper C. Osteoporosis. Lancet 2006, 367:2010-2018.
2. Hatoum H.T., Lin S.J., Smith M.R., Barghout V., Lipton A. Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases: analysis of a national medical claims database. Cancer 2008, 113:1438-1445.
3. Migliorati C.A. Bisphosphanates and oral cavity avascular bone necrosis. J Clin Oncol 2003, 21:4253-4254.
4. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003, 61:1115-1117.
5. Wang J., Goodger N.M., Pogrel M.A. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 2003, 61:1104-1107.
6. Ruggiero S.L., Dodson T.B., Assael L.A., Landesberg R., Marx R.E., Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg 2009, 67:2-12.
7. Khosla S., Burr D., Cauley J., Dempster D.W., Ebeling P.R., Felsenberg D., et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007, 22:1479-1491.
8. Pautke C., Bauer F., Bissinger O., Tischer T., Kreutzer K., Steiner T., et al. Tetracycline bone fluorescence: a valuable marker for osteonecrosis characterization and therapy. J Oral Maxillofac Surg 2010, 68:125-129.
9. Abu-Id M.H., Warnke P.H., Gottschalk J., Springer I., Wiltfang J., Acil Y., et al. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. J Craniomaxillofac Surg 2008, 36:95-103.
10. Otto S., Hafner S., Grotz K.A. The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg 2009, 67:589-592.
11. Cheung A., Seeman E. Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. N Engl J Med 2010, 363(25):2473-2474.
12. Hokugo A., Christensen R., Chung E.M., Sung E.C., Felsenfeld A.L., Sayre J.W., et al. Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats. J Bone Miner Res 2010, 25:1337-1349.
13. Biasotto M., Chiandussi S., Zacchigna S., Moimas S., Dore F., Pozzato G., et al. A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw. J Oral Pathol Med 2010, 39:390-396.
14. Lopez-Jornet P., Camacho-Alonso F., Molina-Minano F., Gomez-Garcia F., Vicente-Ortega V. An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats. J Oral Pathol Med 2010, 39:697-702.
15. Maahs M.P., Azambuja A.A., Campos M.M., Salum F.G., Cherubini K. Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats. Head Neck 2011, 33:199-207.
16. Ali-Erdem M., Burak-Cankaya A., Cemil-Isler S., Demircan S., Soluk M., Kasapoglu C., et al. Extraction socket healing in rats treated with bisphosphonate: animal model for bisphosphonate related osteonecrosis of jaws in multiple myeloma patients. Med Oral Patol Oral Cir Bucal 2011, 16:e879-e883.
17. Sonis S.T., Watkins B.A., Lyng G.D., Lerman M.A., Anderson K.C. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol 2009, 45:164-172.
18. Lelovas P.P., Xanthos T.T., Thoma S.E., Lyritis G.P., Dontas I.A. The laboratory rat as an animal model for osteoporosis research. Comp Med 2008, 58:424-430.
19. Recker R.R., Kimmel D.B., Dempster D., Weinstein R.S., Wronski T.J., Burr D.B. Issues in modern bone histomorphometry. Bone 2011, 49:955-964.
20. Mosekilde L., Weisbrode S.E., Safron J.A., Stills H.F., Jankowsky M.L., Ebert D.C., et al. Calcium-restricted ovariectomized Sinclair S-1 minipigs: an animal model of osteopenia and trabecular plate perforation. Bone 1993, 14:379-382.
21. Hickey J.S., O'Neal R.B., Scheidt M.J., Strong S.L., Turgeon D., Van Dyke T.E. Microbiologic characterization of ligature-induced peri-implantitis in the microswine model. J Periodontol 1991, 62:548-553.
22. Laiblin C., Jaeschke G. Clinical chemistry examinations of bone and muscle metabolism under stress in the Gottingen miniature pig - an experimental study. Berl Munch Tierarztl Wochenschr 1979, 92:124-128.
23. Tsutsumi H., Katagiri K., Takeda S., Nasu T., Igarashi S., Tanigawa M., et al. Standardized data and relationship between bone growth and bone metabolism in female Gottingen minipigs. Exp Anim 2004, 53:331-337.
24. Bloebaum R.D., Ota D.T., Skedros J.G., Mantas J.P. Comparison of human and canine external femoral morphologies in the context of total hip replacement. J Biomed Mater Res 1993, 27:1149-1159.
25. Aerssens J., Boonen S., Lowet G., Dequeker J. Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. Endocrinology 1998, 139:663-670.
26. Allen M.R., Burr D.B. Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 2008, 66:987-994.
27. Allen M.R., Kubek D.J., Burr D.B. Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs. J Bone Miner Res 2010, 25:98-105.
28. Allen M.R., Kubek D.J., Burr D.B., Ruggiero S.L., Chu T.M. Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs. Osteoporos Int 2011, 22:693-702.
29. Clinical Biochemistry of Domestic Animals 2008, Academic Press/Elsevier, San Diego. sixth ed. J.J. Kaneko, J.W. Harvey, M.L. Bruss (Eds.).
30. Otto S., Pautke C., Opelz C., Westphal I., Drosse I., Schwager J., et al. Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism. J Oral Maxillofac Surg 2010, 68:2837-2845.
31. Otto S., Hafner S., Mast G., Tischer T., Volkmer E., Schieker M., et al. Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle?. J Oral Maxillofac Surg 2010, 68:1158-1161.
32. Tsutsumi H., Katagiri K., Morimoto M., Nasu T., Tanigawa M., Mamba K. Diurnal variation and age-related changes of bone turnover markers in female Gottingen minipigs. Lab Anim 2004, 38:439-446.
33. Turner R.T., Maran A., Lotinun S., Hefferan T., Evans G.L., Zhang M., et al. Animal models for osteoporosis. Rev Endocr Metab Disord 2001, 2:117-127.
34. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007, 65:369-376.
35. Pautke C., Bauer F., Tischer T., Kreutzer K., Weitz J., Kesting M., et al. Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg 2009, 67:471-476.
36. Pautke C., Bauer F., Otto S., Tischer T., Steiner T., Weitz J., et al. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study. J Oral Maxillofac Surg 2011, 69:84-91.
37. Geist L. Die Regeneration des Unterkiefers nach totaler Necrose durch Phophordämpfe 1852, 66. Verlag von Ferdinand Enke, Erlangen.
38. Huja S.S., Mason A., Fenell C.E., Mo X., Hueni S., D'Atri A.M., et al. Effects of short-term zoledronic acid treatment on bone remodeling and healing at surgical sites in the maxilla and mandible of aged dogs. J Oral Maxillofac Surg 2011, 69:418-427.
39. Bi Y., Gao Y., Ehirchiou D., Cao C., Kikuiri T., Le A., et al. Bisphosphonates cause osteonecrosis of the jaw-like disease in mice. Am J Pathol 2010, 177:280-290.
40. Otto S., Schuler K., Ihrler S., Ehrenfeld M., Mast G. Osteonecrosis or metastases of the jaw or both? Case report and review of the literature. J Oral Maxillofac Surg 2010, 68:1185-1188.
41. Badros A., Weikel D., Salama A., Goloubeva O., Schneider A., Rapoport A., et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006, 24:945-952.
42. Dimopoulos M.A., Kastritis E., Bamia C., Melakopoulos I., Gika D., Roussou M., et al. Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 2009, 20:117-120.
43. Vahtsevanos K., Kyrgidis A., Verrou E., Katodritou E., Triaridis S., Andreadis C.G., et al. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol 2009, 27:5356-5362.
44. Agis H., Blei J., Watzek G., Gruber R. Is zoledronate toxic to human periodontal fibroblasts?. J Dent Res 2010, 89:40-45.
45. Walter C., Klein M.O., Pabst A., Al-Nawas B., Duschner H., Ziebart T. Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells. Clin Oral Investig 2010, 14:35-41.
46. Russell R.G., Watts N.B., Ebetino F.H., Rogers M.J. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 2008, 19:733-759.